{"id":11469,"date":"2022-07-01T20:38:32","date_gmt":"2022-07-02T00:38:32","guid":{"rendered":"https:\/\/www.cancerresearch.org\/event\/fiercepharma-virtuals-asco-preview-what-to-watch-for\/"},"modified":"2022-07-14T15:07:50","modified_gmt":"2022-07-14T19:07:50","slug":"fiercepharma-virtual-asco-preview-webinar","status":"publish","type":"cri_events","link":"https:\/\/www.cancerresearch.org\/es\/events\/fiercepharma-virtual-asco-preview-webinar","title":{"rendered":"FiercePharma Virtual’s ASCO Preview: What to Watch For"},"content":{"rendered":"

Vanessa Lucey, PhD, MBA<\/a>, director of CRI Clinical Accelerator and Venture Fund, is an "ASCO Preview" webinar speaker. <\/strong><\/p>\n

On May 27, 3-4 pm ET, FiercePharma begins their virtual series "ASCO Explained: Expert predictions and takeaways from the world's biggest cancer meeting"<\/a> with "ASCO Preview: What to watch for."<\/p>\n

As we head into ASCO weekend, cancer experts will highlight closely watched data sets to be unveiled at the virtual meeting—and discuss how they could change prescribing patterns. This discussion will take a close look at oncology's hottest fields, including CAR-T and precision medicine, as panelists zero in on the conference's most highly anticipated studies, 2020's biggest research trends, and the data they're most looking forward to seeing.<\/p>\n

Webinar speakers include Jennifer Keating Litton, MD, Vice President ad interim of Clinical Research, The University of Texas MD Anderson Cancer Center; Vanessa M. Lucey, PhD, MBA, Director, CRI Venture Fund and Clinical Accelerator; and Andrew Berens, MD, Managing Director, Targeted Oncology<\/em>, SVB Leerink.<\/p>\n

The "ASCO\u200b Postview: Highlights from the virtual conference" takes place on Monday, June 1, 2020 at 3:00pm ET.<\/p>\n","protected":false},"excerpt":{"rendered":"

CRI's Vanessa Lucey, PhD, MBA, speaks on the "ASCO Preview" webinar on May 27, 2020, at 3 p.m. ET. <\/p>\n","protected":false},"featured_media":4143,"template":"","events_categories":[203],"resource_cancer_types":[],"resource_patient_age":[],"resource_cancer_stage":[],"resource_treatment_type":[],"resource_treatment_status":[],"class_list":["post-11469","cri_events","type-cri_events","status-publish","has-post-thumbnail","hentry","events_categories-cri-speaks"],"acf":[],"yoast_head":"\nFiercePharma Virtual's ASCO Preview: What to Watch For<\/title>\n<meta name=\"description\" content=\"CRI's Vanessa Lucey, PhD, MBA, speaks on the "ASCO Preview"\u00a0webinar on May 27, 2020, at 3 p.m. ET.\u00a0\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.cancerresearch.org\/events\/fiercepharma-virtual-asco-preview-webinar\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"FiercePharma Virtual's ASCO Preview: What to Watch For\" \/>\n<meta property=\"og:description\" content=\"CRI's Vanessa Lucey, PhD, MBA, speaks on the "ASCO Preview"\u00a0webinar on May 27, 2020, at 3 p.m. ET.\u00a0\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.cancerresearch.org\/events\/fiercepharma-virtual-asco-preview-webinar\" \/>\n<meta property=\"og:site_name\" content=\"Cancer Research Institute\" \/>\n<meta property=\"article:modified_time\" content=\"2022-07-14T19:07:50+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/ede9a390-3d45-4108-bfad-27adc141af7d.png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:title\" content=\"FiercePharma Virtual's ASCO Preview: What to Watch For\" \/>\n<meta name=\"twitter:description\" content=\"CRI's Vanessa Lucey, PhD, MBA, speaks on the "ASCO Preview"\u00a0webinar on May 27, 2020, at 3 p.m. ET.\u00a0\" \/>\n<meta name=\"twitter:image\" content=\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/ede9a390-3d45-4108-bfad-27adc141af7d.png\" \/>\n<meta name=\"twitter:label1\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minuto\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.cancerresearch.org\/events\/fiercepharma-virtual-asco-preview-webinar\",\"url\":\"https:\/\/www.cancerresearch.org\/events\/fiercepharma-virtual-asco-preview-webinar\",\"name\":\"FiercePharma Virtual's ASCO Preview: What to Watch For\",\"isPartOf\":{\"@id\":\"https:\/\/www.cancerresearch.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.cancerresearch.org\/events\/fiercepharma-virtual-asco-preview-webinar#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.cancerresearch.org\/events\/fiercepharma-virtual-asco-preview-webinar#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/b6243db7-620e-4583-9250-ef5a4320a899.png\",\"datePublished\":\"2022-07-02T00:38:32+00:00\",\"dateModified\":\"2022-07-14T19:07:50+00:00\",\"description\":\"CRI's Vanessa Lucey, PhD, MBA, speaks on the \\\"ASCO Preview\\\"\u00a0webinar on May 27, 2020, at 3 p.m. ET.\u00a0\",\"breadcrumb\":{\"@id\":\"https:\/\/www.cancerresearch.org\/events\/fiercepharma-virtual-asco-preview-webinar#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.cancerresearch.org\/events\/fiercepharma-virtual-asco-preview-webinar\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.cancerresearch.org\/events\/fiercepharma-virtual-asco-preview-webinar#primaryimage\",\"url\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/b6243db7-620e-4583-9250-ef5a4320a899.png\",\"contentUrl\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/b6243db7-620e-4583-9250-ef5a4320a899.png\",\"width\":700,\"height\":500},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.cancerresearch.org\/events\/fiercepharma-virtual-asco-preview-webinar#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.cancerresearch.org\/es\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Event\",\"item\":\"https:\/\/www.cancerresearch.org\/events\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"FiercePharma Virtual’s ASCO Preview: What to Watch For\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.cancerresearch.org\/#website\",\"url\":\"https:\/\/www.cancerresearch.org\/\",\"name\":\"Cancer Research Institute\",\"description\":\"For a World Immune to Cancer\",\"publisher\":{\"@id\":\"https:\/\/www.cancerresearch.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.cancerresearch.org\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.cancerresearch.org\/#organization\",\"name\":\"Cancer Research Institute\",\"url\":\"https:\/\/www.cancerresearch.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.cancerresearch.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/05\/logo-gradient.svg\",\"contentUrl\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/05\/logo-gradient.svg\",\"width\":156,\"height\":53,\"caption\":\"Cancer Research Institute\"},\"image\":{\"@id\":\"https:\/\/www.cancerresearch.org\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"FiercePharma Virtual's ASCO Preview: What to Watch For","description":"CRI's Vanessa Lucey, PhD, MBA, speaks on the \"ASCO Preview\"\u00a0webinar on May 27, 2020, at 3 p.m. ET.\u00a0","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.cancerresearch.org\/events\/fiercepharma-virtual-asco-preview-webinar","og_locale":"es_ES","og_type":"article","og_title":"FiercePharma Virtual's ASCO Preview: What to Watch For","og_description":"CRI's Vanessa Lucey, PhD, MBA, speaks on the \"ASCO Preview\"\u00a0webinar on May 27, 2020, at 3 p.m. ET.\u00a0","og_url":"https:\/\/www.cancerresearch.org\/events\/fiercepharma-virtual-asco-preview-webinar","og_site_name":"Cancer Research Institute","article_modified_time":"2022-07-14T19:07:50+00:00","og_image":[{"url":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/ede9a390-3d45-4108-bfad-27adc141af7d.png","type":"","width":"","height":""}],"twitter_card":"summary_large_image","twitter_title":"FiercePharma Virtual's ASCO Preview: What to Watch For","twitter_description":"CRI's Vanessa Lucey, PhD, MBA, speaks on the \"ASCO Preview\"\u00a0webinar on May 27, 2020, at 3 p.m. ET.\u00a0","twitter_image":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/ede9a390-3d45-4108-bfad-27adc141af7d.png","twitter_misc":{"Tiempo de lectura":"1 minuto"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.cancerresearch.org\/events\/fiercepharma-virtual-asco-preview-webinar","url":"https:\/\/www.cancerresearch.org\/events\/fiercepharma-virtual-asco-preview-webinar","name":"FiercePharma Virtual's ASCO Preview: What to Watch For","isPartOf":{"@id":"https:\/\/www.cancerresearch.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.cancerresearch.org\/events\/fiercepharma-virtual-asco-preview-webinar#primaryimage"},"image":{"@id":"https:\/\/www.cancerresearch.org\/events\/fiercepharma-virtual-asco-preview-webinar#primaryimage"},"thumbnailUrl":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/b6243db7-620e-4583-9250-ef5a4320a899.png","datePublished":"2022-07-02T00:38:32+00:00","dateModified":"2022-07-14T19:07:50+00:00","description":"CRI's Vanessa Lucey, PhD, MBA, speaks on the \"ASCO Preview\"\u00a0webinar on May 27, 2020, at 3 p.m. ET.\u00a0","breadcrumb":{"@id":"https:\/\/www.cancerresearch.org\/events\/fiercepharma-virtual-asco-preview-webinar#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.cancerresearch.org\/events\/fiercepharma-virtual-asco-preview-webinar"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.cancerresearch.org\/events\/fiercepharma-virtual-asco-preview-webinar#primaryimage","url":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/b6243db7-620e-4583-9250-ef5a4320a899.png","contentUrl":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/b6243db7-620e-4583-9250-ef5a4320a899.png","width":700,"height":500},{"@type":"BreadcrumbList","@id":"https:\/\/www.cancerresearch.org\/events\/fiercepharma-virtual-asco-preview-webinar#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.cancerresearch.org\/es"},{"@type":"ListItem","position":2,"name":"Event","item":"https:\/\/www.cancerresearch.org\/events"},{"@type":"ListItem","position":3,"name":"FiercePharma Virtual’s ASCO Preview: What to Watch For"}]},{"@type":"WebSite","@id":"https:\/\/www.cancerresearch.org\/#website","url":"https:\/\/www.cancerresearch.org\/","name":"Cancer Research Institute","description":"For a World Immune to Cancer","publisher":{"@id":"https:\/\/www.cancerresearch.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cancerresearch.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/www.cancerresearch.org\/#organization","name":"Cancer Research Institute","url":"https:\/\/www.cancerresearch.org\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.cancerresearch.org\/#\/schema\/logo\/image\/","url":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/05\/logo-gradient.svg","contentUrl":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/05\/logo-gradient.svg","width":156,"height":53,"caption":"Cancer Research Institute"},"image":{"@id":"https:\/\/www.cancerresearch.org\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/cri_events\/11469","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/cri_events"}],"about":[{"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/types\/cri_events"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/media\/4143"}],"wp:attachment":[{"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/media?parent=11469"}],"wp:term":[{"taxonomy":"events_categories","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/events_categories?post=11469"},{"taxonomy":"resource_cancer_types","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/resource_cancer_types?post=11469"},{"taxonomy":"resource_patient_age","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/resource_patient_age?post=11469"},{"taxonomy":"resource_cancer_stage","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/resource_cancer_stage?post=11469"},{"taxonomy":"resource_treatment_type","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/resource_treatment_type?post=11469"},{"taxonomy":"resource_treatment_status","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/resource_treatment_status?post=11469"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}